Modulation of nuclear factor-kappa B activity can influence the susceptibility to systemic lupus erythematosus

dc.contributor.authorKalergis, Alexis M.
dc.contributor.authorIruretagoyena, Mirentxu I.
dc.contributor.authorBarrientos, Magaly J.
dc.contributor.authorGonzalez, Pablo A.
dc.contributor.authorHerrada, Andres A.
dc.contributor.authorLeiva, Eduardo D.
dc.contributor.authorGutierrez, Miguel A.
dc.contributor.authorRiedel, Claudia A.
dc.contributor.authorBueno, Susan M.
dc.contributor.authorJacobelli, Sergio H.
dc.date.accessioned2024-01-10T12:06:44Z
dc.date.available2024-01-10T12:06:44Z
dc.date.issued2009
dc.description.abstractP>Autoimmune diseases, such as systemic lupus erythematosus (SLE), result from deficiencies in self-antigen tolerance processes, which require regulated dendritic cell (DC) function. In this study we evaluated the phenotype of DCs during the onset of SLE in a mouse model, in which deletion of the inhibitory receptor Fc gamma RIIb leads to the production of anti-nuclear antibodies and glomerulonephritis. Splenic DCs from Fc gamma RIIb-deficient mice suffering from SLE showed increased expression of co-stimulatory molecules. Furthermore, diseased mice showed an altered function of the nuclear factor-kappa B (NF-kappa B) transcription factor, which is involved in DC maturation. Compared with healthy animals, expression of the inhibitory molecule I kappa B-alpha was significantly decreased in mice suffering from SLE. Consistently, pharmacological inhibition of NF-kappa B activity in Fc gamma RIIb-deficient mice led to reduced susceptibility to SLE and prevented symptoms, such as anti-nuclear antibodies and kidney damage. Our data suggest that the occurrence of SLE is significantly influenced by alterations of NF-kappa B function, which can be considered as a new therapeutic target for this disease.
dc.description.funderFONDECYT
dc.description.funderProyecto
dc.description.funderFONDEF
dc.description.funderMillennium Nucleus on Immunology and Immunotherapy
dc.description.funderVRAID
dc.description.funderCONICYT
dc.fechaingreso.objetodigital2024-05-07
dc.format.extent9 páginas
dc.fuente.origenWOS
dc.identifier.doi10.1111/j.1365-2567.2008.02964.x
dc.identifier.issn0019-2805
dc.identifier.pubmedidMEDLINE:19016912
dc.identifier.urihttps://doi.org/10.1111/j.1365-2567.2008.02964.x
dc.identifier.urihttps://repositorio.uc.cl/handle/11534/76201
dc.identifier.wosidWOS:000268703800015
dc.information.autorucCiencias Biológicas;Bueno SM;S/I;113541
dc.information.autorucCiencias Biológicas;González PA;S/I;15616
dc.information.autorucMedicina;Gutiérrez MA;S/I;68377
dc.information.autorucCiencias Biológicas;Herrada AA;S/I;174374
dc.information.autorucMedicina;Iacobelli SH;S/I;98345
dc.information.autorucMedicina;Iruretagoyena MI;S/I;144496
dc.information.autorucCiencias Biológicas;Kalergis AM;S/I;90610
dc.information.autorucCiencias Biológicas;Leiva ED;S/I;142382
dc.issue.numero1
dc.language.isoen
dc.nota.accesocontenido parcial
dc.publisherWILEY-BLACKWELL PUBLISHING, INC
dc.revistaIMMUNOLOGY
dc.rightsacceso restringido
dc.subjectandrographolide
dc.subjectautoimmunity
dc.subjectdendritic cells
dc.subjectnuclear factor-kappa B
dc.subjectrosiglitazone
dc.subjectsystemic lupus erythematosus
dc.subjectEXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS
dc.subjectPLASMACYTOID DENDRITIC CELLS
dc.subjectT-CELLS
dc.subjectANDROGRAPHIS-PANICULATA
dc.subjectANTIGEN PRESENTATION
dc.subjectGAMMA
dc.subjectACTIVATION
dc.subjectINHIBITION
dc.subjectDISEASE
dc.subjectALPHA
dc.subject.ods03 Good Health and Well-being
dc.subject.odspa03 Salud y bienestar
dc.titleModulation of nuclear factor-kappa B activity can influence the susceptibility to systemic lupus erythematosus
dc.typeartículo
dc.volumen128
sipa.codpersvinculados113541
sipa.codpersvinculados15616
sipa.codpersvinculados68377
sipa.codpersvinculados174374
sipa.codpersvinculados98345
sipa.codpersvinculados144496
sipa.codpersvinculados90610
sipa.codpersvinculados142382
sipa.indexWOS
sipa.indexScopus
sipa.trazabilidadCarga SIPA;09-01-2024
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Modulation of nuclear factor-kappa B activity can influence the susceptibility to systemic lupus erythematosus.pdf
Size:
3.19 KB
Format:
Adobe Portable Document Format
Description: